draeger e diabetes res clin pract 1995 28 139 - Glimerpiride in type 2 diabetes mellitus diabetes melitus menurut who adalah A review of the worldwide Effects of glimepiride on HbA Diabetes Research and Clinical Practice Diabetes Res Clin Pract 199528supplS6780 Crossref PubMed Draeger E Clinical profile of glimepiride Diabetes Res Clin Pract 199528supplS13946 Crossref PubMed Web of Science Google Scholar 24 Rosenstock J Samols E Muchmore DB Schneider J The Glimepiride Study Group Glimepiride a new oncedaily sulfonylurea A 26 Rosskamp R WernickePanten K Draeger E Clinical profile of the novel sulphonylurea glimepiride Diabetes Res Clin Pract 199631SupplS33S42 27 Tsumura K Clinical evaluation of glimepiride HOE490 in NIDDM including a double blind comparative study versus gliclazide Diabetes Res Clin Pract 199528Suppl 51475149 With the approval of several new pharmacologic agents for the treatment of type 2 diabetes however the addition of one or more orally administered agents to sulfonylurea therapy or use of other oral combination therapy is rapidly evolving as a means of optimizing glycemic control In many patients combination therapy can delay the need to Glimepiride Role of a New Sulfonylurea in the Treatment of Type 2 Diabetes Res Clin Pract 1995 Aug28 SupplS13946 doi 101016016882279501072l Author E Draeger 1 Affiliation 1 Hoechst AG Frankfurt Federal Republic of Germany PMID 8529506 DOI 101016016882279501072l Abstract In order to achieve appropriate blood glucose control the treatment of noninsulin dependent NIDDM Type II Diabetes Res Clin Pract R Rosskamp 1 K WernickePanten E Draeger Affiliation 1 Hoechst AG Clinical Research H 840 D65926 Frankfurt Germany PMID 8864639 DOI 1010160168822796012284 Abstract Glimepiride is a remarkably safe drug especially in NIDDM patients at high risk eg the renally impaired elderly or bagaimana cara mengetahui seseorang menderita diabetes mellitus physically Combination Therapy For Type 2 Diabetes Endocrine Practice Clinical profile of glimepiride ScienceDirect Clinical profile of glimepiride Semantic Scholar Semantic Scholar extracted view of Clinical profile of glimepiride by E Draeger Clinical profile of glimepiride ITliESlMJiGlEl AtTJ CiJi1lCJl1 PJl1CITTGIE ELSEVIER Diabetes Research and Clinical Practice 28 Supp 1995 S139S146 Clinical profile of glimepiride Eberhard Draeger Clinical Research Building H840 Hoechst AG 65926Frankfurt Federal Republic of Germany Abstract In order to achieve appropriate blood glucose control the treatment Clinical profile of the novel sulphonylurea glimepiride E Draeger Diabetes Research and Clinical Practice 28 Suppl I995 S139S146 2 Results of clinical trials Treatment of noninsulin dependent NIDDM Type II diabetes has the primary goal of restoring blood glucose to normal levels in order to avoid acute symptoms of hyperglycaemia and to pre vent or at least to delay the development of Clinical profile of glimepiride PubMed Draeger E Clinical profile of glimepiride Diabetes Res Clin Pract 1995 28Suppl 13946 Article Google Scholar Draeger KE WernickePanten K Lomp HJ et al Longterm treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride Amaryl a doubleblind comparison with glibenclamide Horm Metab Res 1996 28 Sulphonylureas are effective and well tolerated in patients with Type 2 diabetes but may be associated with weight gain and lack of compliance due to multiple daily dosing This open uncontrolled surveillance study examined the efficacy and safety of glimepiride a new sulphonylurea administered once daily in patients with Type 2 diabetes A total of 1770 patients were enrolled in the Efficacy and Tolerability of diabetes melitus pada ibu hamil Glimepiride in Daily Practice
diabetes treatment history
tepung maizena untuk diabetes
